Allarity Therapeutics, Inc. Quarterly Depreciation, Depletion and Amortization in USD from Q1 2021 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Allarity Therapeutics, Inc. annual/quarterly Depreciation, Depletion and Amortization history and growth rate from Q1 2021 to Q1 2022.
  • Allarity Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2022 was $23K, a 58.9% decline year-over-year.
  • Allarity Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2022 was $60K, a 43.4% decline from 2021.
  • Allarity Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2021 was $106K, a 130% increase from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $23K -$33K -58.9% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-27
Q1 2021 $56K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.